Singular Genomics Systems Past Performance
How has Singular Genomics Systems performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Last years earnings growth
Earnings and Revenue History
Quality Earnings: OMIC is currently unprofitable.
Growing Profit Margin: OMIC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if OMIC's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare OMIC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OMIC is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (13.6%).
Return on Equity
High ROE: OMIC has a negative Return on Equity (-32.33%), as it is currently unprofitable.